4.6 Review

Conversion of Stem Cells to Cancer Stem Cells: Undercurrent of Cancer Initiation

Journal

CANCERS
Volume 11, Issue 3, Pages -

Publisher

MDPI
DOI: 10.3390/cancers11030345

Keywords

stem cell; cancer stem cells; induced pluripotent stem cells; cancer-inducing niche; chronic inflammation

Categories

Ask authors/readers for more resources

Cancer stem cells (CSCs) also known as cancer-initiating cells (CIC), are responsible for the sustained and uncontrolled growth of malignant tumors and are proposed to play significant roles in metastasis and recurrence. Several hypotheses have proposed that the events in either stem and/or differentiated cells, such as genomic instability, inflammatory microenvironment, cell fusion, and lateral gene transfer, should be considered as the possible origin of CSCs. However, until now, the exact origin of CSC has been obscure. The development of induced pluripotent stem cells (iPSCs) in 2007, by Yamanaka's group, has been met with much fervency and hailed as a breakthrough discovery by the scientific and research communities, especially in regeneration therapy. The studies on the development of CSC from iPSCs should also open a new page of cancer research, which will help in designing new therapies applicable to CSCs. Currently most reviews have focused on CSCs and CSC niches. However, the insight into the niche before the CSC niche should also be of keen interest. This review introduces the novel concept of cancer initiation introducing the conversion of iPSCs to CSCs and proposes a relationship between the inflammatory microenvironment and cancer initiation as the key concept of the cancer-inducing niche responsible for the development of CSC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Different pancreatic cancer microenvironments convert iPSCs into cancer stem cells exhibiting distinct plasticity with altered gene expression of metabolic pathways

Ghmkin Hassan, Toshiaki Ohara, Said M. Afify, Kazuki Kumon, Maram H. Zahra, Xiaoying Fu, Mohamad Al Kadi, Akimasa Seno, David S. Salomon, Masaharu Seno

Summary: This study found that normal stem cells can be converted into cancer stem cells in the cancer-inducing microenvironment. The converted cells exhibited tumorigenicity and self-renewal characteristics and their drug responses and metastatic abilities varied depending on the microenvironment of cancer cells. Transcriptome analysis showed upregulation of pathways related to aggressiveness and energy production in the converted cells.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Article Multidisciplinary Sciences

The efficacy of PI3Kγ and EGFR inhibitors on the suppression of the characteristics of cancer stem cells

Yanning Xu, Said M. Afify, Juan Du, Bingbing Liu, Ghmkin Hassan, Qing Wang, Hanbo Li, Yixin Liu, Xiaoying Fu, Zhengmao Zhu, Ling Chen, Masaharu Seno

Summary: This study established a model of cancer stem cells (CSCs) derived from mouse induced pluripotent stem cells (miPSCs) and found that the activation of PI3K-Akt and EGFR signaling pathways played significant roles in the process. The inhibitors targeting these pathways showed significant anti-tumor effects in vitro and in vivo, with PI3K-gamma inhibitor Eganelisib demonstrating better therapeutic efficacy and fewer side effects.

SCIENTIFIC REPORTS (2022)

Article Oncology

Cancer-inducing niche: the force of chronic inflammation

Said M. Afify, Ghmkin Hassan, Akimasa Seno, Masaharu Seno

Summary: The growth of cancer tissue is driven by a small group of cells called cancer stem cells, which have the potential to self-renew, differentiate, and form tumors. Chronic diseases like obesity and diabetes may establish an environment that promotes the transformation of undifferentiated cells into cancer stem cells and the development of malignant tumors. Chronic inflammation is believed to play a key role in this process.

BRITISH JOURNAL OF CANCER (2022)

Article Oncology

Up-regulation of Dsg2 confered stem cells with malignancy through wnt/β-catenin signaling pathway

Ling Chen, Yanxia Liu, Yanning Xu, Said M. Afify, Ang Gao, Juan Du, Bingbing Liu, Xiaoying Fu, Yixin Liu, Ting Yan, Zhengmao Zhu, Masaharu Seno

Summary: In this study, it was discovered that the up-regulation of Dsg2 expression during the conversion of miPSCs into CSCs activates the Wnt/beta-catenin signaling pathway, implying a potential mechanism for the transformation of stem cells into a malignant phenotype.

EXPERIMENTAL CELL RESEARCH (2023)

Article Biotechnology & Applied Microbiology

GSK-3α/β and MEK inhibitors assist the microenvironment of tumor initiation

Ghmkin Hassan, Said M. Afify, Maram H. Zahra, Hend M. Nawara, Kazuki Kumon, Yoshiaki Iwasaki, David S. Salomon, Akimasa Seno, Masaharu Seno

Summary: Researchers have successfully converted human induced pluripotent stem cells into cancer stem cells by culturing them in a medium mimicking the microenvironment of tumor initiation. The converted cells exhibited characteristics of cancer stem cells and could be used to establish personalized cancer models for studying tumor initiation and screening personalized therapies.

CYTOTECHNOLOGY (2023)

Article Engineering, Biomedical

Cancer stem cells as the source of tumor associated myoepithelial cells in the tumor microenvironment developing ductal carcinoma in situ

Said M. Afify, Ghmkin Hassan, Maram H. Zahra, Hend M. Nawara, Hagar A. Abu Quora, Amira Osman, Hager Mansour, Kazuki Kumon, Akimasa Seno, Ling Chen, Ayano Satoh, David S. Salomon, Masaharu Seno

Summary: Tumor associated myoepithelial cells (TAMEs) are a crucial population in the tumor microenvironment, originating from cancer stem cells (CSCs) and playing a key role in tumor development.

BIOMATERIALS (2023)

Meeting Abstract Oncology

Cancer stem cell model derived from human glioma cells and human pancreatic cancer cells

Hiroko Ishii, Maram Zahra, Ghmkin Hassan, Masaharu Seno

CANCER SCIENCE (2022)

Meeting Abstract Oncology

Inhibition of self-renewal, migration, and invasion of cancer stem cells by blocking NADPH oxidase.

Monzur Sadia, Ghmkin Hassan, Said M. Affify, Hager Mansour, Mona Sheta, Kazuki Kumon, Maram H. Zahra, Akimasa Seno, Masaharu Seno

CANCER SCIENCE (2022)

Meeting Abstract Oncology

Cancer stem cell property can be promoted by IL-17A depending on its developmental environment

Akimasa Seno, Maram Zahra, Masaharu Seno

CANCER SCIENCE (2022)

Meeting Abstract Oncology

MEK and GSK-3 inhibitors enhance the microenvironment of tumor initiation

Hassan Ghmkin, Said M. Afify, Maram H. Zahara, David S. Salomon, Akimasa Seno, Masaharu Seno

CANCER SCIENCE (2022)

No Data Available